# After President Donald Trump's showdown with pharma titans Eli Lilly and Novo Nordisk last month, a seismic shift has unfolded.

*biotech · news · 2025-12-08 · Newsmax*

## Key points

- Eli Lilly and Novo Nordisk have agreed to lower U.S. prices for Ozempic and Wegovy.
- The new pricing aligns American costs for these weight-loss drugs with those in other countries.
- A government-backed pact now permits these drugs to be accessed through Medicare and Medicaid.
- The TrumpRx site has launched to facilitate broader public access to weight-loss medications.

**Companies:** Eli Lilly, Novo Nordisk
**Countries:** United States, Denmark

[Read the full story on Newsmax](https://www.newsmax.com/platinum/donald-trump-obesity-drugs-price/2025/12/05/id/1237197/)

---

Canonical: https://newsio.io/n/dd9dddb8-6548-4195-bdb0-c260e5c0f68c/after-president-donald-trumps-showdown-with-pharma-titans-eli-lilly-and-novo-nor
Summarized by Newsio from Newsmax. https://newsio.io/how-it-works